• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后乳腺癌女性正常乳腺组织中雌激素受体表达的定量分析及其与肿瘤亚型的关系

Quantification of Estrogen Receptor Expression in Normal Breast Tissue in Postmenopausal Women With Breast Cancer and Association With Tumor Subtypes.

作者信息

Gulbahce H Evin, Blair Cindy K, Sweeney Carol, Salama Mohamed E

机构信息

Departments of *Anatomic Pathology, Huntsman Cancer Hospital §Internal Medicine, University of Utah, Salt Lake City, UT †Department of Internal Medicine, University of New Mexico ‡University of New Mexico Cancer Center, Albuquerque, NM.

出版信息

Appl Immunohistochem Mol Morphol. 2017 Sep;25(8):548-552. doi: 10.1097/PAI.0000000000000337.

DOI:10.1097/PAI.0000000000000337
PMID:27490758
Abstract

Estrogen exposure is important in the pathogenesis of breast cancer and is a contributing risk factor. In this study we quantified estrogen receptor (ER) alpha expression in normal breast epithelium (NBR) in women with breast cancer and correlated it with breast cancer subtypes. Tissue microarrays were constructed from 204 breast cancer patients for whom normal breast tissue away from tumor was available. Slides stained with ER were scanned and expression in normal terminal duct lobular epithelium was quantitated using computer-assisted image analysis. ER expression in normal terminal duct lobular epithelium of postmenopausal women with breast cancer was significantly associated with estrogen and triple (estrogen, progesterone receptors, and HER2) negative phenotypes. Also increased age at diagnosis was significantly associated with ER expression in NBR. ER positivity in normal epithelium did not vary by tumor size, lymph node status, tumor grade, or stage. On the basis of quantitative image analysis, we confirm that ER expression in NBR increases with age in women with breast cancer, and report for the first time, a significant association between ER expression in NBR with ER-negative and triple-negative cancers in postmenopausal women.

摘要

雌激素暴露在乳腺癌发病机制中很重要,是一个促成风险因素。在本研究中,我们对乳腺癌女性正常乳腺上皮(NBR)中的雌激素受体(ER)α表达进行了定量,并将其与乳腺癌亚型相关联。从204例有远离肿瘤的正常乳腺组织的乳腺癌患者构建组织微阵列。扫描用ER染色的玻片,使用计算机辅助图像分析对正常终末导管小叶上皮中的表达进行定量。绝经后乳腺癌女性正常终末导管小叶上皮中的ER表达与雌激素及三阴性(雌激素、孕激素受体和HER2)表型显著相关。此外,诊断时年龄增加与NBR中的ER表达显著相关。正常上皮中的ER阳性在肿瘤大小、淋巴结状态、肿瘤分级或分期方面无差异。基于定量图像分析,我们证实乳腺癌女性中NBR的ER表达随年龄增加,并且首次报道绝经后女性NBR中的ER表达与ER阴性和三阴性癌症之间存在显著关联。

相似文献

1
Quantification of Estrogen Receptor Expression in Normal Breast Tissue in Postmenopausal Women With Breast Cancer and Association With Tumor Subtypes.绝经后乳腺癌女性正常乳腺组织中雌激素受体表达的定量分析及其与肿瘤亚型的关系
Appl Immunohistochem Mol Morphol. 2017 Sep;25(8):548-552. doi: 10.1097/PAI.0000000000000337.
2
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.预测雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌早期和晚期远处复发的临床病理因素
Breast Cancer. 2016 Nov;23(6):830-843. doi: 10.1007/s12282-015-0649-0. Epub 2015 Oct 14.
3
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.高Ki-67表达和低孕激素受体表达可独立导致雌激素受体阳性且人表皮生长因子受体2阴性的绝经后乳腺癌患者预后较差。
Clin Breast Cancer. 2015 Jun;15(3):204-11. doi: 10.1016/j.clbc.2014.12.007. Epub 2014 Dec 24.
4
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.雌激素受体阳性乳腺癌绝经前后女性之间孕激素受体、FOXA1、GATA3和p53的差异表达
Breast Cancer Res Treat. 2014 Apr;144(2):249-61. doi: 10.1007/s10549-014-2867-0. Epub 2014 Feb 19.
5
Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.在周围浸润性乳腺癌的正常终末导管小叶单位中雌激素受体和孕激素受体的表达。
Breast Cancer Res Treat. 2013 Feb;137(3):837-47. doi: 10.1007/s10549-012-2380-2. Epub 2012 Dec 28.
6
Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.维生素D缺乏与绝经后女性乳腺癌的不良预后特征相关。
J Steroid Biochem Mol Biol. 2017 Nov;174:284-289. doi: 10.1016/j.jsbmb.2017.10.009. Epub 2017 Oct 12.
7
Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.体重指数(BMI)与乳腺癌:对绝经前和绝经后妇女肿瘤组织病理学特征、癌症亚型和复发率的影响。
Gynecol Endocrinol. 2013 Mar;29(3):263-7. doi: 10.3109/09513590.2012.736559. Epub 2012 Nov 23.
8
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.使用定量氟-18氟脱氧葡萄糖/正电子发射断层扫描成像参数比较三阴性乳腺癌与雌激素受体阳性/孕激素受体阳性/人表皮生长因子受体2阴性乳腺癌:一种对疾病特征描述可能有用的方法。
Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226.
9
Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.血清雌酮水平与绝经后日本女性雌激素受体阳性乳腺癌风险的关联。
Clin Cancer Res. 2003 Jun;9(6):2229-33.
10
Risk factors for hormone receptor-defined breast cancer in postmenopausal women.绝经后女性激素受体定义的乳腺癌的危险因素。
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8. doi: 10.1158/1055-9965.EPI-06-0489.

引用本文的文献

1
Assessment of , , , and mRNA in Hormone Receptor-Positive Early Breast Cancer: A Cross-Sectional Study.激素受体阳性早期乳腺癌中、、、和mRNA的评估:一项横断面研究
Health Sci Rep. 2025 Jul 15;8(7):e71062. doi: 10.1002/hsr2.71062. eCollection 2025 Jul.
2
Population attributable risk of a competing-risk model for breast cancer and non-breast cancer death among women ≥ 65 years.≥65岁女性中乳腺癌和非乳腺癌死亡竞争风险模型的人群归因风险
Breast Cancer Res Treat. 2025 Jun;211(3):687-698. doi: 10.1007/s10549-025-07683-w. Epub 2025 Mar 25.
3
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers.
年轻与老年雌激素受体阳性且人表皮生长因子受体2阴性乳腺癌之间的分子差异。
NPJ Breast Cancer. 2022 Nov 7;8(1):119. doi: 10.1038/s41523-022-00492-0.
4
A review of prognostic and predictive biomarkers in breast cancer.乳腺癌预后和预测生物标志物综述。
Clin Exp Med. 2023 Feb;23(1):1-16. doi: 10.1007/s10238-021-00781-1. Epub 2022 Jan 15.
5
Inter-Individual Variation in Response to Estrogen in Human Breast Explants.人类乳腺外植体对雌激素反应的个体间差异。
J Mammary Gland Biol Neoplasia. 2020 Mar;25(1):51-68. doi: 10.1007/s10911-020-09446-3. Epub 2020 Mar 9.
6
Association between low estrogen receptor positive breast cancer and staining performance.低雌激素受体阳性乳腺癌与染色表现之间的关联
NPJ Breast Cancer. 2020 Feb 5;6:5. doi: 10.1038/s41523-020-0146-2. eCollection 2020.